Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$169,875,333
+$58,447 QoQ
Shares Held
2,922,335
0.0% QoQ
Ownership
1.96%
of shares outstanding
% of Portfolio
9.39%
of 13F equity value
Holder Rank
#13
of 325 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names. PCVX ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDX |
Celldex Therapeutics, Inc.
|
5,322,908 | $198,065,406 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $175,993,963 | |
| 3 | PCVX |
Vaxcyte, Inc.
This page
|
2,922,335 | $169,875,333 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
3,667,097 | $141,916,653 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,890,059 | $124,012,431 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,453,877 | $118,557,720 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,000,000 | $113,620,000 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
2,840,792 | $97,495,981 |
All Filings in PCVX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169,875,333 | 2,922,335 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $169,816,886 | 2,922,335 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $134,836,536 | 2,922,335 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $110,638,599 | 3,071,588 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $99,857,325 | 3,071,588 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $120,832,000 | 3,200,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $191,290,120 | 2,336,796 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $118,759,439 | 1,039,288 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $56,877,152 | 753,240 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $50,890,950 | 745,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $62,951,159 | 1,002,407 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $66,396,708 | 1,302,407 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $64,922,000 | 1,300,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $45,605,064 | 1,216,784 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $33,729,995 | 703,441 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,767,312 | 698,638 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,749,474 | 723,781 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,998,306 | 579,640 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,031,180 | 211,483 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||